227 related articles for article (PubMed ID: 26043337)
1. Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.
Schimmelmann BG; Michel C; Martz-Irngartinger A; Linder C; Schultze-Lutter F
World Psychiatry; 2015 Jun; 14(2):189-97. PubMed ID: 26043337
[TBL] [Abstract][Full Text] [Related]
2. Age effect on prevalence of ultra-high risk for psychosis symptoms: replication in a clinical sample of an early detection of psychosis service.
Schultze-Lutter F; Hubl D; Schimmelmann BG; Michel C
Eur Child Adolesc Psychiatry; 2017 Nov; 26(11):1401-1405. PubMed ID: 28456857
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) study.
Schultze-Lutter F; Michel C; Ruhrmann S; Schimmelmann BG
Schizophr Bull; 2014 Nov; 40(6):1499-508. PubMed ID: 24353096
[TBL] [Abstract][Full Text] [Related]
4. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
[TBL] [Abstract][Full Text] [Related]
5. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
6. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
Nelson B; Yuen K; Yung AR
Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
[TBL] [Abstract][Full Text] [Related]
7. Effects of age and sex on clinical high-risk for psychosis in the community.
Schultze-Lutter F; Schimmelmann BG; Flückiger R; Michel C
World J Psychiatry; 2020 May; 10(5):101-124. PubMed ID: 32477906
[TBL] [Abstract][Full Text] [Related]
8. The significance of at-risk symptoms for psychosis in children and adolescents.
Schimmelmann BG; Walger P; Schultze-Lutter F
Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
[TBL] [Abstract][Full Text] [Related]
9. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
[TBL] [Abstract][Full Text] [Related]
11. An ecological momentary assessment study of age effects on perceptive and non-perceptive clinical high-risk symptoms of psychosis.
Michel C; Lerch S; Büetiger JR; Flückiger R; Cavelti M; Koenig J; Kaess M; Kindler J
Eur Child Adolesc Psychiatry; 2023 Oct; 32(10):1841-1852. PubMed ID: 35585271
[TBL] [Abstract][Full Text] [Related]
12. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
13. DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders.
Salazar de Pablo G; Guinart D; Cornblatt BA; Auther AM; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Lo Cascio N; Brandizzi M; Arango C; Moreno C; Van Meter A; Fusar-Poli P; Correll CU
Front Psychiatry; 2020; 11():568982. PubMed ID: 33192693
[No Abstract] [Full Text] [Related]
14. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
15. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
Rekhi G; Rapisarda A; Lee J
Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile, conversion rate, and suicidal thinking and behaviour in children and adolescents at ultra-high risk for psychosis: a theoretical perspective.
Pontillo M; Tata MC; Averna R; Gargiullo P; Guerrera S; Vicari S
Res Psychother; 2020 May; 23(1):455. PubMed ID: 32913830
[TBL] [Abstract][Full Text] [Related]
17. Basic Symptoms Are Associated With Age in Patients With a Clinical High-Risk State for Psychosis: Results From the PRONIA Study.
Walger H; Antonucci LA; Pigoni A; Upthegrove R; Salokangas RKR; Lencer R; Chisholm K; Riecher-Rössler A; Haidl T; Meisenzahl E; Rosen M; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Falkai P; Ruef A; Hietala J; Pantelis C; Wood SJ; Brambilla P; Bertolino A; Borgwardt S; Koutsouleris N; Schultze-Lutter F
Front Psychiatry; 2020; 11():552175. PubMed ID: 33312133
[TBL] [Abstract][Full Text] [Related]
18. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations.
Schultze-Lutter F; Renner F; Paruch J; Julkowski D; Klosterkötter J; Ruhrmann S
Psychopathology; 2014; 47(3):194-201. PubMed ID: 24192655
[TBL] [Abstract][Full Text] [Related]
19. EPA guidance on the early detection of clinical high risk states of psychoses.
Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk.
Fusar-Poli P; Cappucciati M; De Micheli A; Rutigliano G; Bonoldi I; Tognin S; Ramella-Cravaro V; Castagnini A; McGuire P
Schizophr Bull; 2017 Jan; 43(1):48-56. PubMed ID: 28053130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
